Group A streptococcal disease in paediatric inpatients: a European perspective.

Boeddha, Navin P; Atkins, Lucy; de Groot, Ronald; Driessen, Gertjan; Hazelzet, Jan; Zenz, Werner; Carrol, Enitan D; Anderson, Suzanne T; Martinon-Torres, Federico; Agyeman, Philipp K A; Galassini, Rachel; Herberg, Jethro; Levin, Michael; Schlapbach, Luregn J; Emonts, Marieke (2023). Group A streptococcal disease in paediatric inpatients: a European perspective. European journal of pediatrics, 182(2), pp. 697-706. Springer-Verlag 10.1007/s00431-022-04718-y

[img] Text
s00431-022-04718-y.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

UNLABELLED

Group A streptococcal (GAS) disease shows increasing incidence worldwide. We characterised children admitted with GAS infection to European hospitals and studied risk factors for severity and disability. This is a prospective, multicentre, cohort study (embedded in EUCLIDS and the Swiss Pediatric Sepsis Study) including 320 children, aged 1 month to 18 years, admitted with GAS infection to 41 hospitals in 6 European countries from 2012 to 2016. Demographic, clinical, microbiological and outcome data were collected. A total of 195 (61%) patients had sepsis. Two hundred thirty-six (74%) patients had GAS detected from a normally sterile site. The most common infection sites were the lower respiratory tract (LRTI) (22%), skin and soft tissue (SSTI) (23%) and bone and joint (19%). Compared to patients not admitted to PICU, patients admitted to PICU more commonly had LRTI (39 vs 8%), infection without a focus (22 vs 8%) and intracranial infection (9 vs 3%); less commonly had SSTI and bone and joint infections (p < 0.001); and were younger (median 40 (IQR 21-83) vs 56 (IQR 36-85) months, p = 0.01). Six PICU patients (2%) died. Sequelae at discharge from hospital were largely limited to patients admitted to PICU (29 vs 3%, p < 0.001; 12% overall) and included neurodisability, amputation, skin grafts, hearing loss and need for surgery. More patients were recruited in winter and spring (p < 0.001).

CONCLUSION

In an era of observed marked reduction in vaccine-preventable infections, GAS infection requiring hospital admission is still associated with significant severe disease in younger children, and short- and long-term morbidity. Further advances are required in the prevention and early recognition of GAS disease.

WHAT IS KNOWN

• Despite temporal and geographical variability, there is an increase of incidence of infection with group A streptococci. However, data on the epidemiology of group A streptococcal infections in European children is limited.

WHAT IS NEW

• In a large, prospective cohort of children with community-acquired bacterial infection requiring hospitalisation in Europe, GAS was the most frequent pathogen, with 12% disability at discharge, and 2% mortality in patients with GAS infection. • In children with GAS sepsis, IVIG was used in only 4.6% of patients and clindamycin in 29% of patients.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine > Paediatric Infectiology

UniBE Contributor:

Agyeman, Philipp Kwame Abayie

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0340-6199

Publisher:

Springer-Verlag

Language:

English

Submitter:

Anette van Dorland

Date Deposited:

01 Dec 2022 08:58

Last Modified:

06 Feb 2023 00:14

Publisher DOI:

10.1007/s00431-022-04718-y

Related URLs:

PubMed ID:

36449079

Uncontrolled Keywords:

Child Hospital Outcome Streptococcus pyogenes

BORIS DOI:

10.48350/175373

URI:

https://boris.unibe.ch/id/eprint/175373

Actions (login required)

Edit item Edit item
Provide Feedback